<DOC>
	<DOCNO>NCT01213160</DOCNO>
	<brief_summary>The primary purpose study explore safety tolerability AZD4547 Japanese patient advance solid malignancy .</brief_summary>
	<brief_title>Study Assess Safety Tolerability AZD4547 Japanese Patient</brief_title>
	<detailed_description>A Phase I , Open-Label , Multicentre Study Assess Safety , Tolerability , Pharmacokinetics Preliminary Anti-tumour Activity Ascending Doses AZD4547 Japanese Patients Advanced Solid Malignancies .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Japanese patient advance solid malignancy Over 25 year old Relatively good overall health cancer Poor bone marrow function ( produce enough blood cell ) . Poor liver kidney function . Refractory nausea vomiting , chronic gastrointestinal disease , inability swallow IP previous significant bowel resection .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>150 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Phase I</keyword>
	<keyword>cancer</keyword>
	<keyword>solid tumour</keyword>
	<keyword>advanced solid malignancy</keyword>
	<keyword>dose escalation</keyword>
	<keyword>FGFR TKI</keyword>
	<keyword>Japanese</keyword>
</DOC>